Predicting outcomes in newborns with blood clotting problems
Part of Blood & lymphatic clinical trials.
This study aims to see if a scoring system can help predict the outcome for newborns with DIC, a condition where blood clotting is abnormal. It may help doctors better understand and manage this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby must be between birth and 28 days old (up to 28 days of life).
- Baby must have been diagnosed with DIC (disseminated intravascular coagulation), a serious blood clotting problem.
- Baby's mother must not have ITP (immune thrombocytopenia, a low platelet condition).
- Baby must not have autoimmune thrombocytopenia (low platelets from the immune system attacking them).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how bleeding problems in patients with cancer affect the body's ability to break down blood clots. Researchers hope to find better ways to manage and treat these complications.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This study aims to find early signs of a serious blood-clotting problem that can happen with septic shock. It tests a new way to detect this condition earlier, so doctors can treat it more quickly and improve outcomes.
This study looks at how the body stops bleeding or forms clots in people with bleeding or clotting disorders. It may help researchers understand these conditions better and improve evaluation tests.
This study is looking at a new way to detect bleeding between the mother and baby during pregnancy (called fetomaternal hemorrhage), which can lead to a blood problem in the newborn called hemolytic disease. The goal is to see if this test can help diagnose the condition earlier and hopefully improve care for the baby.
This trial looks at how to estimate bleeding risk in newborns who are very premature and have a low platelet count. The goal is to guide safer care by better identifying which babies may be at higher risk of bleeding.
Hear when a new Disseminated Intravascular Coagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.